Efficiency of Traumeel S Application in Combined Therapy of Acute Sinusitis in Children

The article presents the results of researches on the effect of combination bioregulatory drug Traumeel S, manufactured by Biologische Heilmittel Heel GmbH, on the clinical efficacy of treatment for acute sinusitis in children on the background of basic therapy. Evaluation of treatment efficacy was...

Full description

Bibliographic Details
Main Authors: O.I. Smiian, O.P. Moshchych, T.P. Bynda, M.M. Dychko
Format: Article
Language:English
Published: Publishing House Zaslavsky 2016-05-01
Series:Zdorovʹe Rebenka
Subjects:
Online Access:http://childshealth.zaslavsky.com.ua/article/view/76590
Description
Summary:The article presents the results of researches on the effect of combination bioregulatory drug Traumeel S, manufactured by Biologische Heilmittel Heel GmbH, on the clinical efficacy of treatment for acute sinusitis in children on the background of basic therapy. Evaluation of treatment efficacy was performed by determining the integrated hematological indices, calculated on the basis of indicators of clinical blood tests and markers of inflammation (total protein and its fractions, C-reactive protein). The inclusion of Traumeel S into the treatment regimens in patients with acute sinusitis showed significantly more rapid decline in leukocyte index of intoxication, and the completion of inflammation. This medicine is effective and well tolerated by patients.
ISSN:2224-0551
2307-1168